About Mark Emlick
Mark Emlick is a highly experienced professional investor with a substantial portfolio of both commercial and development property under personal ownership in addition to equity investments in several businesses around the globe. Mark has been responsible for setting up and structuring significant property, private equity and energy opportunities with revenues in excess of $1.5 billion. He has raised over $1 billion for investment deals ranging from property investment and real estate development to private equity.
Announcing the latest news on our latest development in Wimbledon. Two properties in a prime location: Copse Hill, Wimbledon, London.
The opening line in a speech is important. As a business man, I hear pitches every day. Everyone wants to sound inspirational from the beginning. To tell you the truth, not everyone manages it but sometimes I am surprised and even inspired…
Through Consensus Capital Group, Mark Emlick has become a joint venture partner in the UK business of Clubtan. Clubtan is a tanning studio concept established in Denmark in 1995.
Mark Emlick, CEO of Consensus Capital Group has made an investment of venture capital in an online marketing platform for lottery syndicates which enable players to share their lottery syndicates across social networks. Syndie is an easy way to play global lottery games with friends.
Mark Emlick’s investment in Groupvest continues to perform well with residential property developments. Groupvest matches high net worth investors with independent property developers who require capital investment. Two new Groupvest developments are in progress:
Mark Emlick through Consensus Capital Group, has invested in a 35 Mega Watt Gas Peaking plant at Westshore Fraserburgh. Read on to find out more.
Turning a landmark local into a contemporary home needed tact as well as imagination
Tucked away around the North West side of Edinburgh’s spectacular New Town is an unlikely cul de sac, a row of mews properties behind the grander town houses of Edinburgh’s spectacular West End.
Charles River Laboratories, the global clinical research company is expanding its operations in the East of Scotland with the opening of a new administrative office at Heriot-Watt Research Park in Edinburgh.